Data-driven medicine firm Sophia Genetics has appointed its new chief financial officer in the form of Valentin Matillon.
He brings over two decades worth of experience in senior financial management positions to the group, holding roles in technology organisations including SITA, Hewlett-Packard and Electronic Arts.
He said: “Our ground breaking technology and approach are revolutionising the healthcare field, improving the prognosis of patients worldwide and I look forward to supporting the company through its journey of growth and development.”
Matillon joins Sophia Genetics from the Hobart Group, where he served as senior director of finance.
His new role will see him take responsibility for the company’s finance and accounting functions.
Jurgi Camblong, chief executive officer and co-founder of Sophia Genetics, said: “Matillon’s track record in transforming finance functions and supporting new acquisitions, along with his pragmatic and results-driven approach, make him a natural fit for the fast-paced culture of Sophia Genetics.”